ALLO icon

Allogene Therapeutics
ALLO

Overview Fund Activity

169 hedge funds and large institutions have $2.26B invested in Allogene Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 55 reducing their positions, and 29 closing their positions.

Holders
169
Holders Change
-12
Holders Change %
-6.63%
% of All Funds
2.97%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
18
Increased
54
Reduced
55
Closed
29
Calls
$2.18M
Puts
$4.17M
Net Calls
-$1.99M
Net Calls Change
-$2M

Top Buyers

1
CC
1
Casdin Capital
New York
$54M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$85.4M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$112M
4
State Street
4
State Street
Massachusetts
$90.3M
5
Ameriprise
5
Ameriprise
Minnesota
$9.81M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
Marshall Wace
2
Marshall Wace
United Kingdom
$0
3
Norges Bank
3
Norges Bank
Norway
$30.2M
4
MWNA
4
Marshall Wace North America
New York
$0
5
Millennium Management
5
Millennium Management
New York
$5.88M
Name Market Value Shares Shares
Change 		Shares
Change %
EW
201
Evoke Wealth
California
$0 32 – –
GKWIM
202
Gerber Kawasaki Wealth & Investment Management
California
$0 10 +10 New
5 6 7 8
9